Does Probe's Eye Subthalamic nucleus length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?

Öz:

AMAÇ: STN DBS ilerlemiş Parkinson hastalığı olan hastaların tedavisinde kabul görmüş bir tedavi metodudur. Derin beyin stimülasyonunun(DBS) cerrahi planlaması yapılırken subtalamik nukleusun (STN) uzunluğu göz önünde bulundurulur ve intraoperatif olarak mikroelektrodkayıtla (MER) doğrulanır. Bu çalışmada T2 ağırlıklı MRda probe eye ile ölçülen STN uzunluğunun intraoperatif MERle ölçülen STN uzunluğu ilene kadar örtüştüğünü araştırdık.yÖntem ve GeReÇleR: STN DBS cerrahisi uygulanan 10 Parkinson hastasını inceledik. Probe eye görüntüdeki STN uzunluğu ve STNi geçensantral MER elektrodunun trasesinin uzunluğu hesaplandı. BULGULAR: Analizimiz T2 ağırlıklı probe eye görüntüdeki STN uzunluğu ile MER arasında istatistiksel açıdan anlamlı fark olmadığını gösterdi. SONUÇ: STNnin giriş ve çıkış noktaları preoperatif probe eye görüntüsü kullanılarak doğru bir şekilde belirlenebilir.

Anahtar Kelime:

Konular: Cerrahi

Derin Beyin Stimülasyonu Uygulanan Parkinson Hastalarında T2W MR da Probe Eye ile Ölçülen Subtalamik Nukleus Uzunluğu, Mikroelektrod Kayıtla Uyumlu mu?

Öz:

AIM: Subthalamic nucleus (STN) deep brain stimulation (DBS) has become a well-accepted treatment for patients with advanced Parkinson sdisease (PD). During surgical planning for DBS, the length of the STN is taken into account and verified during microelectrode recording (MER)intraoperatively. Here, we addressed the question to which extent the length of the STN measured with the T2 weighted MRI in the probe s eyeview corresponded with the intraoperatively determined length of the STN with MER.MATERIAL and METHODS: We included 10 consecutive Parkinson s disease patients who underwent STN DBS surgery. The length of the STNin the probe s eye view mode was calculated along the trajectory of the central MER electrode crossing the STN.Results: Our analysis showed no statistical difference between the length of the STN measured with the T2 weighted probe s eye view modeand the MER (right STN length 5.8 ± 0.9 mm MRI vs. 6.3 ± 0.5 mm MER, p>0.05; left STN length 5.6 ± 0.4 mm MRI vs 5.8 ± 1 mm MER, p>0.05).CONCLUSION: This means that the entry and the exit of the STN can be adequately estimated using the probe s eye view preoperatively.

Anahtar Kelime:

Konular: Cerrahi

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Acar F, Miller JP, Berk MC, Anderson G, Burchiel KJ: Safety o anterior commissure-posterior commissure-based target cal culation of the subthalamic nucleus in functional stereotacti procedures. Stereotact Funct Neurosurg. 85(6):287-291, 2007
2. Binder DK, Rau GM, Starr PA: Risk factors for hemorrhage during microelectrode- guided deep brain stimulator imp lantation for movement disorders. Neurosurgery 56(4) 722732, 2005
3. Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfe H, Bötzel K, Daniels C, Deutschländer A, Dillmann U, Eisne W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A Schneider GH, Schnitzler A, Steude U, Sturm V, Timmerman L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voge J; German Parkinson Study Group, Neurostimulation Section A randomized trial of deep-brain stimulation for Parkinson disease. N Engl J Med 355:896-908, 2006
4. Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P Marks WJ Jr, Rothlind J, Sagher O, Moy C, Pahwa R, Burchie K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ; CSP 468 Study Group: Pallida versus subthalamic deep-brain stimulation for Parkinson disease. N Engl J Med 362(22):2077-2091, 2010
5. Hamani C, Richter EO, Andrade-Souza Y, Hutchison W, Saint Cyr JA, Lozano AM: Correspondence of microelectrode mapping with magnetic resonance imaging for subthalami nucleus procedures. Surg Neurol 63(3):249-253, 2005
6. Hariz MI: Safety and risk of microelectrode recording i surgery for movement disorders. Stereotact Funct Neurosurg 78: 146157, 2002
7. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P: Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinsons disease. N Engl J Med 349:1925-1934, 2003
8. Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas JF, Broussolle E, Perret JE, Benabid AL: Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345: 91-95, 1995
9. Mandat TS, Hurwitz T, Honey CR: Hypomania as an adverse effect of subthalamic nucleus stimulation: Report of two cases. Acta Neurochir 148(8):895-897; discussion 898, 2006
10. Odekerken VJ, van Laar T, Staal MJ, Mosch A, Hoffmann CF, Nijssen PC, Beute GN, van Vugt JP, Lenders MW, Contarino MF, Mink MS, Bour LJ, van den Munckhof P, Schmand BA, de Haan RJ, Schuurman PR, de Bie RM: Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinsons disease (NSTAPS study): A randomised controlled trial. Lancet Neurol 12(1):37-44, 2012
11. Pollak P, Benabid AL, Gross C, Gao DM, Laurent A, Benazzouz A, Hoffmann D, Gentil M, Perret J: Effects of the stimulation of the subthalamic nucleus in Parkinson disease. Rev Neurol 149:175-176, 1993
12. Rodriguez-Oroz MC, Moro E, Krack P: Long-term outcomes of surgical therapies for Parkinsons disease. Mov Disord 27(14):1718-1728, 2012
13. Schilbach L, Weiss PH, Kuhn J, Timmermann L, Klosterkötter J, Huff W: Pharmacological treatment of deep brain stimulation-induced hypomania leads to clinical remission while preserving motor benefits. Neurocase 18(2):152-159, 2102
14. Schlaier JR, Habermeyer C, Warnat J, Lange M, Janzen A, Hochreiter A, Proescholdt M, Brawanski A, Fellner C: Discrepancies between the MRI- and the electrophysiologically defined subthalamic nucleus. Acta Neurochir 153(12):2307- 2318, 2011
15. Spiegel J, Fuss G, Backens M, Reith W, Magnus T, Becker G, Moringlane JR, Dillmann U: Transient dystonia following magnetic resonance imaging in a patient with deep brain stimulation electrodes for the treatment of Parkinson disease. Case report. J Neurosurg 4: 772-774, 2003
16. Starr PA, Vitek JL, DeLong M, Bakay RA: Magnetic resonance imaging-based stereotactic localization of the globus pallidus and subthalamic nucleus. Neurosurgery 44(2): 303-313; discussion 313-314, 1999
17. Temel Y, Wilbrink P, Duits A, Boon P, Tromp S, Ackermans L, van Kranen-Mastenbroek V, Weber W, Visser-Vandewalle V: Single electrode and multiple electrode guided electrical stimulation of the subthalamic nucleus in advanced Parkinsons disease. Neurosurgery 61: 346-355; discussion 355-357, 2007
18. Temel Y, Prinsenberg T, Visser-Vandewalle V: Imaging of the subthalamic nucleus for deep brain stimulation: A systematic review. Neuromodulation 11(1):8-12, 2008
19. Xiaowu H, Xiufeng J, Xiaoping Z, Bin H, Laixing W, Yiqun C, Jinchuan L, Aiguo J, Jianmin L: Risks of intracranial hemorrhage in patients with Parkinsons disease receiving deep brain stimulation and ablation. Parkinsonism Relat Disord 16(2):96-100, 2010
20. Zhu XL, Hamel W, Schrader B, Weinert D, Hedderich J, Herzog J, Volkmann J, Deuschl G, Müller D, Mehdorn HM: Magnetic resonance imaging-based morphometry and landmark correlation of basal ganglia nuclei. Acta Neurochir 144(10):959-969, 2002

APA	KOCABIÇAK E, AYGÜN D, OZAYDIN I, JAHANSHAHI A, SONNY K, ONAR M, Böke Ö, kurt m, GÜZ H, TERZİ M, ALPTEKIN O, TEMEL Y (2013). Does Probe's Eye Subthalamic nucleus length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?. , 658 - 665.
Chicago	KOCABIÇAK ERSOY,AYGÜN Dursun,OZAYDIN Ilkay,JAHANSHAHI Ali,SONNY K. H TAN,ONAR Musa,Böke Ömer,kurt murat,GÜZ Hatice,TERZİ Murat,ALPTEKIN Onur,TEMEL Yasin Does Probe's Eye Subthalamic nucleus length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?. (2013): 658 - 665.
MLA	KOCABIÇAK ERSOY,AYGÜN Dursun,OZAYDIN Ilkay,JAHANSHAHI Ali,SONNY K. H TAN,ONAR Musa,Böke Ömer,kurt murat,GÜZ Hatice,TERZİ Murat,ALPTEKIN Onur,TEMEL Yasin Does Probe's Eye Subthalamic nucleus length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?. , 2013, ss.658 - 665.
AMA	KOCABIÇAK E,AYGÜN D,OZAYDIN I,JAHANSHAHI A,SONNY K,ONAR M,Böke Ö,kurt m,GÜZ H,TERZİ M,ALPTEKIN O,TEMEL Y Does Probe's Eye Subthalamic nucleus length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?. . 2013; 658 - 665.
Vancouver	KOCABIÇAK E,AYGÜN D,OZAYDIN I,JAHANSHAHI A,SONNY K,ONAR M,Böke Ö,kurt m,GÜZ H,TERZİ M,ALPTEKIN O,TEMEL Y Does Probe's Eye Subthalamic nucleus length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?. . 2013; 658 - 665.
IEEE	KOCABIÇAK E,AYGÜN D,OZAYDIN I,JAHANSHAHI A,SONNY K,ONAR M,Böke Ö,kurt m,GÜZ H,TERZİ M,ALPTEKIN O,TEMEL Y "Does Probe's Eye Subthalamic nucleus length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?." , ss.658 - 665, 2013.
ISNAD	KOCABIÇAK, ERSOY vd. "Does Probe's Eye Subthalamic nucleus length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?". (2013), 658-665.

APA	KOCABIÇAK E, AYGÜN D, OZAYDIN I, JAHANSHAHI A, SONNY K, ONAR M, Böke Ö, kurt m, GÜZ H, TERZİ M, ALPTEKIN O, TEMEL Y (2013). Does Probe's Eye Subthalamic nucleus length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?. Turkish Neurosurgery, 23(5), 658 - 665.
Chicago	KOCABIÇAK ERSOY,AYGÜN Dursun,OZAYDIN Ilkay,JAHANSHAHI Ali,SONNY K. H TAN,ONAR Musa,Böke Ömer,kurt murat,GÜZ Hatice,TERZİ Murat,ALPTEKIN Onur,TEMEL Yasin Does Probe's Eye Subthalamic nucleus length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?. Turkish Neurosurgery 23, no.5 (2013): 658 - 665.
MLA	KOCABIÇAK ERSOY,AYGÜN Dursun,OZAYDIN Ilkay,JAHANSHAHI Ali,SONNY K. H TAN,ONAR Musa,Böke Ömer,kurt murat,GÜZ Hatice,TERZİ Murat,ALPTEKIN Onur,TEMEL Yasin Does Probe's Eye Subthalamic nucleus length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?. Turkish Neurosurgery, vol.23, no.5, 2013, ss.658 - 665.
AMA	KOCABIÇAK E,AYGÜN D,OZAYDIN I,JAHANSHAHI A,SONNY K,ONAR M,Böke Ö,kurt m,GÜZ H,TERZİ M,ALPTEKIN O,TEMEL Y Does Probe's Eye Subthalamic nucleus length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?. Turkish Neurosurgery. 2013; 23(5): 658 - 665.
Vancouver	KOCABIÇAK E,AYGÜN D,OZAYDIN I,JAHANSHAHI A,SONNY K,ONAR M,Böke Ö,kurt m,GÜZ H,TERZİ M,ALPTEKIN O,TEMEL Y Does Probe's Eye Subthalamic nucleus length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?. Turkish Neurosurgery. 2013; 23(5): 658 - 665.
IEEE	KOCABIÇAK E,AYGÜN D,OZAYDIN I,JAHANSHAHI A,SONNY K,ONAR M,Böke Ö,kurt m,GÜZ H,TERZİ M,ALPTEKIN O,TEMEL Y "Does Probe's Eye Subthalamic nucleus length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?." Turkish Neurosurgery, 23, ss.658 - 665, 2013.
ISNAD	KOCABIÇAK, ERSOY vd. "Does Probe's Eye Subthalamic nucleus length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?". Turkish Neurosurgery 23/5 (2013), 658-665.